GPNMB and frontotemporal dementia: GPNMB levels were significantly up regulated (p < 0.05) in the FTD-GRN group (3.07 ± 0.35 ng/mL CSF) compared to controls (1.92 ± 0.31 ng/mL CSF) (Fig. 7d).